{
    "cancelStatus": "1",
    "cancelDate": "2023-08-04",
    "cancelReason": [
        "838"
    ],
    "licid": "06016196",
    "validDate": "2021-03-22 00:00:00.000",
    "issueDate": "2006-03-22 00:00:00.000",
    "licKind": "09",
    "oldLicid": null,
    "certNo": "DHA00601619600",
    "prodNameC": "\"西門子\" N抗人類血清胞漿素原試劑",
    "prodNameE": "\"Siemens\" N Antiserum to Human-Plasminogen",
    "indicationsName": [],
    "does": null,
    "packageUnit": [],
    "medMCode": null,
    "maMedCode": null,
    "medDCode": null,
    "ingredientsDesc": [
        "N Antisera liquid animals sera and are produced by immunization of rabbits with highly purified human fibrinogen, antithrombin III, plasminogen, or C1 Inhibitor, Labile components are removed from the antisera by a special procedure."
    ],
    "restraintItemsCode": [
        "R02"
    ],
    "applicantName": "西門子醫療設備股份有限公司",
    "applicantAddr": "台北市南港區園區街3號2樓之2",
    "medClass": "2",
    "efficacy": "作為定性測量血清及血漿中凝血因子和C1抑制物的診斷試劑。 ",
    "mdFormat": "OSCB09-2mL",
    "productAnnotation": null,
    "mdKind": [
        {
            "mdKindMCode": "C",
            "mdKindMCodeName": "C 免疫學及微生物學裝置",
            "mdKindDCode": "C.5715",
            "mdKindDCodeName": "C.5715 胞漿素原免疫試驗系統",
            "checkChange": "Y"
        }
    ],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "factoryCode": "1",
            "factoryName": "SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH",
            "factoryAddr": "EMIL-VON-BEHRING-STRABE. 76, D-35041 MARBURG, GERMANY",
            "factoryCompanyAddr": "",
            "countryCode": "DE",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "MDE0189000",
            "factoryInfo": "1",
            "qsd": "QSD5584"
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": null,
            "ingredientsDesc": "N Antisera liquid animals sera and are produced by immunization of rabbits with highly purified human fibrinogen, antithrombin III, plasminogen, or C1 Inhibitor, Labile components are removed from the antisera by a special procedure.",
            "concentDesc": null,
            "concent": null,
            "concentUnit": null,
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "2"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [
        {
            "fileType": "1",
            "fileName": "060161960001.pdf",
            "fileStreamId": "E35EA841-2B31-41F3-8145-BC822F6BCDED"
        }
    ],
    "changeDtoList": [],
    "atcList": [],
    "licBaseId": "DA860896-5936-4DB3-9099-3EEB719071C4"
}